Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/IRCT20140512017666N1
IRCT20140512017666N1RecruitingPhase 3

Study of the effect of oral nicorandil on ST-segment resolution in patients with acute ST-segment myocardial infarction undegoing primary coronary angioplasty

Tabriz University of Medical Sciences0 sites240 target enrollmentStarted: TBDLast updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditions

Trial Snapshot

Phase
Phase 3
Status
Recruiting
Enrollment
240
Study OverviewEligibility CriteriaInvestigatorsRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
18 years to no limit (—)
Sex
All

Inclusion Criteria

  • •patients with first acute STEMI treated with primary angioplasty
  • •STEMI definition: Anginal chest pain more than 20 minutes,admission within 12 hours of symptoms onset,ECG ST-segment elevation with at least 2 contiguous ECG leads, >2 fold increase in cardiac enzymes.

Exclusion Criteria

  • •previous history of ischemic heart disease
  • •left bundle branch block,paced rhythm,uninterpretable electrocardiogram,severe valvular disease,cardiomyopathy
  • •coronary anatomy unsuitable for angioplasty including those requiring coronary by-pass surgery or those candidate for medical treatment

Investigators

Similar Trials

Recruiting
Phase 2
The effect of nicorandil on arrhythmia
IRCT20181104041555N1Zahedan University of Medical Sciences100
Recruiting
Phase 3
Evaluation of the oral Nicorandil effect on reducing the contrast-inducedcardiac catheterization.
IRCT20210620051631N1Mashhad University of Medical Sciences344
Recruiting
Phase 3
Effect of Nicorandil on contrast-induced nephropathycontrast-induced nephropathy.Nephropathy induced by other drugs, medicaments and biological substancesICD 10- N1
IRCT20230110057096N1Rasht University of Medical Sciences264
Recruiting
Not Applicable
Oral nicorandil given in off pump coronary artery bypass graft patients reduces acute kidney injury
CTRI/2022/09/045380Mehta Institute of Cardiology and Research center
Recruiting
Phase 4
A Study to Evaluate the Impact of Pre-procedural Intracoronary Nicorandil Injection to PREVENT reductioN Of decREased TIMI FLOW in Patients Who Undergoing Percutaneous Coronary Intervention for the Coronary Artery DiseaseNo-Reflow PhenomenonPercutaneous Coronary InterventionCoronary Artery Disease
NCT05427786Korea University Anam Hospital458